PharmaceuticalsGenerative AIAgentic AICode Generation
Novo Nordisk accelerates clinical insight with custom agents on Azure
Novo Nordisk wanted to accelerate pharmaceutical R&D decision-making by helping researchers explore and validate clinical hypotheses faster using AI-assisted quantitative analysis. Working with Microsoft's AI Acceleration Studio (Forward Deployed Engineering team), Novo Nordisk built a governed reasoning agent on Azure, drawing on its FounData initiative which harmonized more than 200,000 patient-years of clinical trial data aligned to CDISC, SDTM, and ADaM industry standards. The agent lets researchers ask complex scientific questions in natural language and generate and execute code against proprietary clinical datasets, with human-in-the-loop validation by biostatisticians before outputs influence decisions. Before production rollout, the teams ran thousands of automated tests and layered evaluation systems. The solution is reducing time to insight from weeks to minutes and increasing the number of scientific questions teams can evaluate from roughly 5-10 strong ideas per quarter to 50+.
Novo Nordisk A/S· Denmark
Microsoft Azure · Microsoft AI Acceleration Studio
